Pharmaceutical startups are popping up to bring science and sterility to the inquiry surrounding the human microbiome. A couple have already begun testing bacterial medicines in hopes of finding the right strain or stains of bacteria to cure widespread and still mysterious illnesses.
The Food and Drug Administration recently issued its first-ever approval of an artificial pancreas that may make life easier and healthier for such patients. The device, made by Minneapolis-based Medtronics, relies on a computer algorithm to sync the results of a continuous reading of the wearer’s glucose levels and with a pump that provides appropriate amounts of insulin.
The Food and Drug Administration (FDA) has approved the Argus II artificial retina to restore partial sight to patients who are blind. The device, sometimes dubbed a bionic eye, was designed at the Lawrence Livermore National Laboratory to help people who suffer from retinitis pigmentosa, a hereditary degenerative disease that causes degradation of retinal function. Although it does not restore full sight to the visually challenged, those with the disease are able to once have limited, low-resolution vision.
Right on the heels of a new at-home HIV test receiving FDA approval comes word that the first HIV prevention pill has also been approved. Produced by Gilead Sciences, the… read more
The blind in Europe have reason to rejoice, the world’s most advanced artificial retina has just received the CE Mark, approved for use in new patients. The Argus II, developed… read more
This past Sunday (September 19th) the US FDA held one of the final meetings needed to approve genetically modified salmon for human consumption. If approved, the salmon would be the… read more
Twenty years ago, researchers made serious headway in the battle against Alzheimer’s disease (AD). They discovered a link between the brain damage in AD patients and plaque deposits in the… read more
A telescopic implant that fits directly into the eye to treat certain kinds of blindness has finally received FDA approval for use in the US after more than five years… read more
Huge news for Seattle based Dendreon (NASDAQ: DNDN) – the US Food and Drug Administration has finally approved Provenge (Sipuleucel-T) for use in treating metastisized prostate cancer as of April… read more
Stem cell treatments continue to gain ground in the United States. Louisiana based TCA Cellular Therapy has 6 FDA clinical trials in progress, the latest of which is the first… read more